Since its inception in 2018, Redcliffe Labs has endeavoured to be a disrupter in India’s medical lab diagnostics ecosystem. In this talk at RED 2022, founder and managing director Dheeraj Jain discusses some of the company’s key strategic initiatives, such as the use of temperature controlled transport bags and an AI/ML supported infrastructure with a complete ‘Glucose to Genetics’ approach.
Redcliffe Labs founder discusses new era of diagnostics in India’s medical lab ecosystem
十一月 23, 2022
文章

訂閱 Lab Insights 最新新聞和更新

訂閱 Lab Insights 最新新聞和更新

更多相同主題
Select a related post from the options below.
接下來讀取